1-10 of 10
Michel Blanc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide (LEN) In Lower-Risk Myelodysplastic Syndromes (MDS) with Karyotypes Other Than Deletion 5q and Refractory to Erythropoiesis-Stimulating Agents (ESAs)

David Sibon, Giovanna Cannas, Fiorenza Barraco, Thomas Prebet, M.D., Ph.D., Norbert Vey, MD, Anne Banos, MD, Caroline Besson, Selim Corm, Michel Blanc, Borhane Slama, Hervé Perrier, Pierre Fenaux, MD, PhD, Eric Wattel
Journal: Blood
Blood (2010) 116 (21): 4002.
https://doi.org/10.1182/blood.V116.21.4002.4002
Published: 2010
Journal Articles

Risk of AML Evolution In Lower Risk MDS with Del 5q Treated with or without Lenalidomide. A Report by the Groupe Francophone Des Myelodysplasies (GFM)

Lionel Ades, Fabien Lebras, Marie Sebert, Charikleia Kelaidi, Thierry Lamy, Francois Dreyfus, Jacques Delaunay, Sorin Visanica, Pascal Turlure, MD, Agnes Guerci, Marie Paule Cabrol, Anne Banos, Michel Blanc, Norbert Vey, Virginie Eclache, Sylvie Chevret, Pierre Fenaux
Journal: Blood
Blood (2010) 116 (21): 976.
https://doi.org/10.1182/blood.V116.21.976.976
Published: 2010
Journal Articles

Rituximab and Reduced Dose CHOP (R-mini-CHOP) for Patients Over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-7B

Frederic Peyrade, Fabrice Jardin, MD, PhD, Christian Gisselbrecht, Antoine Thyss, Jean François Emile, MD, Sylvie Castaigne, MD, Bertrand Coiffier, MD, PhD, Corinne Haioun, MD, Serge Bologna, Olivier Fitoussi, Gerard Lepeu, MD, Christophe Fruchart, Dominique Bordessoule, PhD, Michel Blanc, MD, Richard Delarue, Maud Janvier, MD, Bruno Salles, MD, Andre Bosly, MD, Herve Tilly
Journal: Blood
Blood (2010) 116 (21): 853.
https://doi.org/10.1182/blood.V116.21.853.853
Published: 2010
Journal Articles

R-CHOP14 Compared to R-CHOP21 in Elderly Patients with Diffuse Large B-Cell Lymphoma: Results of the Interim Analysis of the LNH03-6B GELA Study.

Richard Delarue, MD, Herve Tilly, MD, Gilles Salles, MD, PhD, Christian Gisselbrecht, MD, Nicolas Mounier, MD, Marion Fournier, Thierry Jo Molina, MD, Caroline Bonmati, MD, Hervé Ghesquieres, MD, Michel Blanc, MD, Delphine Germain, Laurence Girard, Corinne Haioun, MD, Andre Bosly, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 406.
https://doi.org/10.1182/blood.V114.22.406.406
Published: 2009
Journal Articles

Treatment of Lower Risk MDS with Del 5q with Lenalidomide (LEN): Results of the French ATU Program.

Fabien Le bras, MD, Marie Sebert, MD, Charikleia Kelaidi, MD, Thierry Lamy, MD, PhD, Francois Dreyfus, MD, PhD, Jacques Delaunay, MD, Anne Banos, MD, Michel Blanc, MD, Norbert Vey, MD, PhD, Martine Gardembas, MD, Sorin Visanica, MD, Frederic Bauduer, MD, Pascal Turlure, MD, Mehdi Dahoun, Odile Beyne-Rauzy, MD, PhD, Agnes Guerci, MD, PhD, Alain Delmer, MD, PhD, Stephane de Botton, MD, PhD, Christian Berthou, MD, Caroline Besson, MD, Delphine Rea, MD, PhD, Francois Lefrere, MD, Eric Wattel, MD, PhD, Philippe Rousselot, MD, PhD, Pierre Fenaux, MD, PhD, Lionel Ades, MD
Journal: Blood
Blood (2009) 114 (22): 2764.
https://doi.org/10.1182/blood.V114.22.2764.2764
Published: 2009
Journal Articles

Treatment of Lower Risk MDS with Del 5q by Lenalidomide, with or without G-CSF: Current Results of the French Patient Named Program (ATU)

Fabien Lebras, Marie Sebert, Virginie Eclache, Thierry Lamy, Jacques Delaunay, Sorin Visanica, Francois Dreyfus, Anne Banos, Michel Blanc, Caroline Besson, Xavier Thomas, Philippe Rodon, Norbert Vey, Martine Gardembas, Frederic Bauduer, MD, Jean-Francois Ramee, Alain Delmer, Delphine Rea, Pascal Turlure, Odile Beyne-Rauzy, Agnes Guerci, Joel Ceccaldi, J. Dugay, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2008) 112 (11): 5069.
https://doi.org/10.1182/blood.V112.11.5069.5069
Published: 2008
Journal Articles

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

Clinical Trials & Observations
Christophe Fermé, Nicolas Mounier, Olivier Casasnovas, Pauline Brice, Marine Divine, Anne Sonet, Fahdela Bouafia, Aspasia Bastard-Stamatoullas, Dominique Bordessoule, Laurent Voillat, Oumedaly Reman, Michel Blanc, Christian Gisselbrecht, for the Groupe d'Etude des Lymphomes de l'Adulte
Journal: Blood
Blood (2006) 107 (12): 4636–4642.
https://doi.org/10.1182/blood-2005-11-4429
Published: 2006
Journal Articles

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Clinical Trials & Observations
Thierry Facon, Jean-Yves Mary, Brigitte Pégourie, Michel Attal, Marc Renaud, Alain Sadoun, Laurent Voillat, Véronique Dorvaux, Cyrille Hulin, Gérard Lepeu, Jean-Luc Harousseau, Jean-Paul Eschard, Augustin Ferrant, Michel Blanc, Frédéric Maloisel, Hubert Orfeuvre, Jean-François Rossi, Isabelle Azaïs, Mathieu Monconduit, Philippe Collet, Bruno Anglaret, Ibrahim Yakoub-Agha, Marc Wetterwald, Houchingue Eghbali, Marie-Christine Vekemans, Hervé Maisonneuve, Jacques Troncy, Bernard Grosbois, Chantal Doyen, Antoine Thyss, Jérome Jaubert, Philippe Casassus, Béatrice Thielemans, Régis Bataille, for the Intergroupe Francophone du Myélome (IFM) group
Journal: Blood
Blood (2006) 107 (4): 1292–1298.
https://doi.org/10.1182/blood-2005-04-1588
Published: 2006
Journal Articles

Comparison of Three Radiation Dose Levels after EBVP Regimen in Favorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-F Trial.

Houchingue Eghbali, MD, Pauline Brice, MD, Geert-Yan Creemers, MD, Marinus van Marwijk Kooij, MD, Patrice Carde, MD, Mars B. Van’t Veer, MD, Elli Lugtenburg, MD, Anne Sonet, MD, Catherine Sebban, MD, Michel Blanc, MD, John M. Raemaekers, MD, Laurent Voillat, MD, Chantal Rieux, Ed M. Noordijk, MD, Michel Henry-Amar, MD
Journal: Blood
Blood (2005) 106 (11): 814.
https://doi.org/10.1182/blood.V106.11.814.814
Published: 2005
Journal Articles

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma

Clinical Trials & Observations
Hervé Tilly, Eric Lepage, Bertrand Coiffier, Michel Blanc, Raoul Herbrecht, André Bosly, Michel Attal, Georges Fillet, Catherine Guettier, Thierry Jo Molina, Christian Gisselbrecht, Félix Reyes, for the Groupe d'Etude des Lymphomes de l'Adulte
Journal: Blood
Blood (2003) 102 (13): 4284–4289.
https://doi.org/10.1182/blood-2003-02-0542
Published: 2003